Kinnate Biopharma Inc (DELISTED) (KNTE:DL)
2.65
0.00 (0.00%)
USD |
NASDAQ |
Apr 03, 16:00
Kinnate Biopharma Accounts Payable (Quarterly): 2.031M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.031M |
| September 30, 2023 | 2.929M |
| June 30, 2023 | 2.696M |
| March 31, 2023 | 4.451M |
| December 31, 2022 | 2.97M |
| September 30, 2022 | 3.058M |
| June 30, 2022 | 2.016M |
| March 31, 2022 | 4.419M |
| Date | Value |
|---|---|
| December 31, 2021 | 3.148M |
| September 30, 2021 | 2.724M |
| June 30, 2021 | 1.334M |
| March 31, 2021 | 3.212M |
| December 31, 2020 | 3.94M |
| September 30, 2020 | 2.328M |
| December 31, 2019 | 0.956M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.956M
Minimum
Dec 2019
4.451M
Maximum
Mar 2023
2.814M
Average
2.929M
Median
Sep 2023
Accounts Payable (Quarterly) Benchmarks
| XOMA Corp | 1.515M |
| Societal CDMO Inc (DELISTED) | 1.312M |
| NGM Biopharmaceuticals Inc (DELISTED) | 2.982M |
| Avrobio Inc | 0.243M |
| Landos Biopharma Inc | 1.565M |